Abstract
Aim. To study the clinical and echocardiographic parameters associated with thrombosis of the left atrial appendage (LAA) and identify independent predictors of LAA thrombosis in patients with nonvalvular atrial fibrillation (AF) before the planned catheter ablation (CA) or cardioversion. Material and methods . A retrospective data analysis of 638 patients with nonvalvular AF directed to hospitalization from 2014 to 2017 for CA or cardioversion was performed. All patients underwent clinical and instrumental examination, including transthoracic and transesophageal echocardiography (TEE). Results . According to TEE the patients were divided into 2 groups: group 1 - 44 patients (7%) with LAA thrombosis and group 2 - 594 patients (93%) without LAA thrombosis. Patients in group 1 had higher risk on CHA2DS2-VASc scale, they were more likely to have coronary artery disease, arterial hypertension, congestive heart failure (stage IIA), obesity >II class, persistent AF. Patients in both groups did not differ in anticoagulant therapy. Patients with LAA thrombosis had enlarged left atrium and right ventricle, increased right atrial volume, left ventricular (LV) end-systolic and end-diastolic diameter, higher LV myocardial mass index, lower LV ejection fraction and blood flow velocity in LAA. Using logistic regression, such independent predictors of LAA thrombosis were detected as severe obesity >II class (OR 2.75; 95% CI 1.33-5.68; p=0.006), persistent AF (OR 2.31; 95 % CI 1.07-4.99; p=0.033), increased diameter of the left atrium (OR 1.13; 95% CI 1.03-1.24; p=0.009), eccentric LV hypertrophy (OR 3.13; 95% CI 1.04-9.40; p=0.042). Conclusion. Thus, in our study we determined independent predictors of LAA thrombosis in patients with nonvalvular AF including clinical factors (obesity and persistent AF) and echocardiographic parameters (diameter of the left atrium and eccentric hypertrophy).
Highlights
A retrospective data analysis of 638 patients with nonvalvular atrial fibrillation (AF) directed to hospitalization from 2014 to 2017 for catheter ablation (CA) or cardioversion was performed
According to transesophageal echocardiography (TEE) the patients were divided into 2 groups: group 1 - 44 patients (7%) with left atrial appendage (LAA) thrombosis and group 2 - 594 patients (93%) without LAA thrombosis
JOURNAL OF ARRHYTHMOLOGY, No 2 (100), 2020 diameter, higher left ventricular (LV) myocardial mass index, lower LV ejection fraction and blood flow velocity in LAA. Using logistic regression, such independent predictors of LAA thrombosis were detected as severe obesity ≥II class, persistent AF, increased diameter of the left atrium, eccentric LV hypertrophy
Summary
A retrospective data analysis of 638 patients with nonvalvular AF directed to hospitalization from 2014 to 2017 for CA or cardioversion was performed. All patients underwent clinical and instrumental examination, including transthoracic and transesophageal echocardiography (TEE)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.